Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Now open for applications. This exciting new course runs from 6 to 8 January 2019 at the University of Oxford.

Are you aware of Experimental Medicine as an approach, but unsure how to begin your own study? Or are you supporting colleagues working on Experimental Medicine research projects, but unsure about the bigger picture?

The NIHR Oxford Health Biomedical Research Centre (NIHR OH BRC) is holding a new course in January 2019, the Oxford Short Course in Experimental Medicine for Mental Health (OxCEMM), for those with a basic understanding of experimental medicine who would like to develop a more comprehensive and practical grounding in this area.

Aimed at clinical and pre-clinical staff and trainees, pharmacists, basic scientists and allied health professionals, it’s an intensive two-and-a-half day course covering what you need to know to develop and conduct experimental medicine studies in mental health.  

With involvement from BRC researchers, from presentations and discussions, to small group exercises and research facility tours, it’s designed to be an interesting and useful programme.

Apply now via this link - limited places. Bursaries and accommodation available. Application deadline 5 October 2018.

Course brochure coming soon. In the meantime, for more information contact oxcemm@psych.ox.ac.uk

Similar stories

Kia Nobre steps down as Head of Department

Matthew Rushworth replaces Kia Nobre as interim Head of the Department of Experimental Psychology

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Experimental Medicine and Industry Partnership

The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.